alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31(c)

I, John K. Morgan, certify that:



|1. | I have reviewed this annual report on Form 10-K/A of Zep Inc.;
|-- | --------------------------------------------------------------



|2. | Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|-- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                                                
|------------------------------------------------
|Date: December 22, 2009                         
|                                                
|/s/ John K. Morgan                              
|John K. Morgan                                  
|Chairman, President, and Chief Executive Officer

[A signed original of this written statement required by Section 302 of the Sarbanes-Oxley Act
has been provided to Zep Inc. and will be retained by Zep Inc. and furnished to the Securities and Exchange Commission or its staff upon request.]
Bernetta Lashay WILLIS, petitioner, v. UNITED STATES.

No. 12-9865.

Supreme Court of the United States

May 28, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
**Exhibit 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We consent to the incorporation byreference in the Registration Statements (Form S-8 No. 333-146804 and Form S-3 No. 333-155235) of DuPont Fabros Technology, Inc. and in the related Prospectus of our reports dated February 24, 2009, with respect to the consolidated financialstatements and schedule of DuPont Fabros Technology, Inc., and the effectiveness of internal control over financial reporting of DuPont Fabros Technology, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2008.

/s/ Ernst & Young LLP 

McLean, Virginia 

February 24, 2009
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

Northern District of California

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

STACY BAUMAN,

Plaintiff,

v.

REMINGTON LODGING & 

HOSPITALIATY, LLC, et al.,

Defendants.

Case No. 17-cv-00627-TSH 

ORDER ALLOWING THE PARTIES 

TO AMEND THEIR PLEADINGS TO 

ADD A NEW PARTY AND TO 

REMAND BACK TO STATE COURT

Re: Dkt. Nos. 49, 51

Pursuant to the stipulation filed and served on October 9, 2018 (ECF No. 51), this Court 

finds that good cause exists to allow Defendant / Cross-Complainant Hilton Worldwide, Inc., and 

Remington Lodging & Hospitality, LLC, and Plaintiff Stacy Bauman, leave of court to amend 

their respective Complaint / Cross-Complaint to name Western State Design, Inc., as a Defendant / 

Cross-Defendant in this action.

This matter is hereby REMANDED back to the Superior Court of Contra Costa as the 

addition of Western State Design, Inc., will defeat diversity pursuant to 28 U.S.C. § 1441(b). The 

Clerk of the Court is ORDERED to close the file. Ecolab, Inc.’s amended motion for summary 

judgment (ECF No. 49) is terminated without prejudice to renewal in state court.

IT IS SO ORDERED.

Dated: October 10, 2018

THOMAS S. HIXSON

United States Magistrate Judge
1

Case No. 17-CV-00220-LHK 

ORDER FOR FTC TO FILE LIST OF AFTERNOON WITNESSES

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

Northern District of California

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

SAN JOSE DIVISION

FEDERAL TRADE COMMISSION,

Plaintiff,

v.

QUALCOMM INCORPORATED,

Defendant.

Case No. 17-CV-00220-LHK 

ORDER FOR FTC TO FILE LIST OF

AFTERNOON WITNESSES

By 12:55 p.m., the FTC shall file a list of the witnesses who will testify the afternoon of 

January 4, 2019, and note whether the witnesses will testify live or by deposition testimony. 

IT IS SO ORDERED.

Dated: January 4, 2019

______________________________________

LUCY H. KOH

United States District Judge

Case 5:17-cv-00220-LHK Document 1108 Filed 01/04/19 Page 1 of 1
あなたのスキンケア製品に何が入っているか、

知っておきましょう

詳しくは

www.fda.gov/healthequity

healthequity@fda.hhs.gov

1-888-INFO-FDA

(1-888-463-6332)

@FDAHealthEquity









スキンケア製品の安全性について

は、 www.fda.gov/SkinFacts. 、

「Get the Skin Facts!」をご覧くだ

さい。

スキンケア製品を使用して良くない

反応が出た場合は、専門医師にご相

談ください。FDAのサイト 

www.fda.gov/medwatch/report.htm

または電話 1-800-FDA-1088. に報告

してください。

知ってい

ますか?

健康リスクのある成分が含まれて

いないか、スキンケア製品のラベ

ルを確認するのが一番です。手製

のラベル、英語以外の言語で書か

れたラベル、または全くラベルの

無い製品は、避けてください。こ

のような製品はFDAの規制に違反

しており、有害製品である可能性

があります。

FDA少数民族の健康

および健康公平性オフィス

美白化粧品

について知っておくべきこと
美白化粧品とは、どういうものですか?

“美白”とは、肌の色素(色)を薄くすることを

目的として販売されている製品で使われる言葉で

す。代替名称としては、以下のようなものが使わ

れています:

• 美白剤または美肌剤

• 皮膚漂白剤

• 肌の色を均一にするスキンケ

ア製品 

• スポット修正剤

• 色あせ防止クリーム

• ケミカルピーリング

美白化粧品は、肌の変色や色素沈着(肝斑)、シ

ミ、そばかす、ニキビ、シワなど、さまざまな

肌の状態を改善する商品だとして宣伝されてい

ます。

ハイドロキノンの健康リスクは?

FDAはハイドロキノンを含む美白製品の使用によ

る発疹、顔の腫れ、恒久的な皮膚の変色(オクロ

ノシス)などの、深刻な副作用の報告を受けてい

ます。

水銀の健康リスクは? 

水銀は神経系、消化器系、免疫系、肺、腎臓、皮

膚、目などに害を与える、毒性の強い金属です。

製品を使用していない同居家族でも、空気中の水

銀蒸気を吸い込んだり、汚染された表面に触れた

りすることで、水銀にさらされる可能性がありま

す。水銀は、特に幼い子供の発達中の脳や神経系

に有害です。

水銀中毒の症状としては、イライラ、震え、視力

や聴力の変化、記憶障害、うつ状態、手足や口の

周りのしびれなどがあります。 

また、水銀中毒は昏睡状態を引き起こし、死に至

ることもあります。

FDAは美白化粧品に含まれるこれらの成

分から市民を守るために、どのような取

り組みをしているのでしょうか? 

ハイドロキノンや水銀を含む美白化粧品の処方箋

無しの店頭販売は、違法です。FDAはこれらの製

品を店頭で販売する者に対して、措置を講じるこ

とができます。 

ハイドロキノンを含む皮膚用医薬品は、医療機関

で処方してもらうことができます。FDAは、安全

で効果的な代替手段が無い場合には、特定の化粧

品にごく少量の水銀を防腐剤として使用すること

を許可しています。しかし、美白化粧品に水銀を

使用することは禁止されています。

市販の美白化粧品を購入する際

は、どのような点に注意すればよ

いでしょうか? 

製品ラベルを読み、ハイドロキノンや水銀の有無

を確認してください。連邦法は、メーカーが米国

で販売されているすべての化粧品または処方箋

無しで購入できる (店頭) 製品のラベルに成分を

記載することを義務付けています。水銀は塩化水

銀、カロメル、mercuric、mercurio、またはHg

と記載されていることがあります。

ハイドロキノンや水銀を含む違法な美白化粧品の

中には、ラベルにこれらの成分が記載されていな

いものがあります。手製のラベル、英語以外の言

語で書かれたラベル、または全くラベルの無い製

品は、避けてください。このような製品はFDAの

規制に違反しており、有害な製品である可能性が

あります。

水銀中毒の症状が見られる場合は、 すぐに毒

物管理センター 1-(800)-222-1222 

に電話し、医療機関に 連絡してください

美白化粧品に

は、有害な成分

は含まれていま

すか? 

ハイドロキノンと水銀

は、クリーム、ローション、石鹸、パウダーなど

の形で販売されている違法な美白化粧品に含まれ

ていることがある成分です。これらの成分を肌に

使用すると、体内に吸収され、使い続けることで

体内に蓄積され、有害となる可能性があります。
Lonnie MCKINNON, Appellant, v. STATE of Florida, Appellee.

Case No. 5D18-619

District Court of Appeal of Florida, Fifth District.

Decision filed May 21, 2019 Rehearing Denied July 1, 2019

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
EXHIBIT 32.2

                           CERTIFICATIONS PURSUANT TO
                             18 U.S.C. SECTION 1350


         I, Lisa K. Vansickle, Senior Vice President and Chief Financial Officer
of First Banks,  Inc. (the "Company"),  certify,  pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

          (1)  The  Quarterly  Report  on  Form  10-Q  of the  Company  for  the
               quarterly  period  ended  March  31,  2008 (the  "Report")  fully
               complies with the  requirements of Sections 13(a) or 15(d) of the
               Securities Exchange Act of 1934; and

          (2)  The information  contained in the Report fairly presents,  in all
               material  respects,   the  financial  condition  and  results  of
               operations of the Company.


Date:  July 30, 2008


                                    By: /s/ Lisa K. Vansickle
                                       -----------------------------------------
                                            Lisa K. Vansickle
                                            Senior Vice President and
                                            Chief Financial Officer
                                            (Principal Financial and Accounting
                                            Officer)
Exhibit 32.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002



In connection with the
Annual report of Osage Exploration and Development, Inc. (the “Company”) on Form 10-K for the period ending December
31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kim Bradford, Chief
Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and
| | --- | -------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------



A signed original of this
written statement required by Section 906 has been provided to Osage Exploration and Development, Inc. and will be retained by
Osage Exploration and Development, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.



|Date:  September 6, 2011 | By:                     | /s/  Kim Bradford
|------------------------ | ----------------------- | -----------------
|                         | Kim Bradford           
|                         | Chief Executive Officer
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

Northern District of California

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

ANTONIO GARCIA, et al.,

Plaintiffs,

v.

TESORO REFINING & MARKETING 

COMPANY LLC, et al.,

Defendants.

Case No. 17-cv-00123-JST 

ORDER VACATING HEARING

Re: ECF No. 107

Before the Court is Plaintiffs’ motion for preliminary approval of class action settlement. 

ECF No. 107. Pursuant to Federal Rule of Civil Procedure 78(b) and Civil Local Rule 7-1(b), the 

Court finds the matter suitable for disposition without oral argument. The hearing on this matter, 

currently scheduled for February 12, 2020, is hereby VACATED.

IT IS SO ORDERED.

Dated: February 4, 2020

______________________________________

JON S. TIGAR

United States District Judge

Case 4:17-cv-00123-JST Document 115 Filed 02/04/20 Page 1 of 1
IN THE SUPREME COURT OF PENNSYLVANIA MIDDLE DISTRICT

**PENNSYLVANIA OFFICE OF ATTORNEY GENERAL,** 

**Petitioner**

**v.**

**SUPERVISING JUDGE OF THE THIRTY FIFTH STATEWIDE INVESTIGATING**  **GRAND JURY,**

**Respondent :** 

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**: No. 171 MM 2014** 

ORDER

PER CURIAM

AND NOW **, this 18 th**  **day of August, 2015, this Court’s order of December 19**

**, 2014, is hereby**  UNSEALED

**.**IN T HE SUPREME COURT OF PENNSYLVANIA MIDDLE DISTRICT

**PENNSYLVANIA OFFICE OF ATTORNEY GENERAL,** 

**Petitioner**

**v.**

**SUPERVISING JUDGE OF THE THIRTY FIFTH STATEWIDE INVESTIGATING**  **GRAND JURY,**

**Respondent :** 

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**: No. 171 MM 2014** 

O R D ER

PER CURIAM

AND NOW **, this 19th day of December, 2014, the Application to File under Seal**

**is** GRANTED **, and the Petition for Review is** DENIED

**. This Court notes that, per the opinion of the Supervising Judge William R.** 

**Carpenter, the purpose of the protective order, entered per the authority of 18 Pa.C.S. §**

**4954, “was/is to prevent the intimidation, obstruction and/or retaliation, in the ordinary**

**sense of those words . . . . [and] was never intended to prevent the [Office of Attorney**

**General] from carrying out its constitutional duties.” Opinion, dated 12/12/2014, at 10-**

**11. Additionally, as explained by Judge Carpenter, the protective order “is not intended**

**to restrict or impact ‘appropriate public [disclosure]’ of information connected with the**

**possession and/or distribution of possibly pornographic images by members of the**

**[Office of Attorney General].” Id. at 11.** 

## UNSEALED PER ORDER OF THE COURT DATED AUGUST 18, 2015**171 MM 2014 - 2**

**Mr. Justice Stevens notes his Dissent and would grant relie f to the OAG in the** 

**Application except for that portion that relates to wi tness intimidation and would direct** 

**that this Order be filed in the normal course of Court business and publically available.**
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr.

, Chief Justice

Michael F. Cavanagh

Marilyn Kelly

Stephen J. Markm an Diane M. Hathaway

Mary Beth Kelly

Brian K. Zahra

, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

_________________________________________ Clerk December 26, 2012

s1217 

# Order

December 26, 2012

145739

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff

- Appellee,

v SC: 145739

COA: 299237

Wayne CC: 09

- 025120

- FC

WILLIAM HAROLD DOTHARD,

Defendant

- Appellant.

_________________________________________/

On order of the Court, the application for leave to appeal the June 26, 2012

judgment of the Court of Appeals is considered, and it is DENIED, because we are not

persuaded that the questions presented should be reviewed by this Court.
R.C. THOMAS, Appellant, v. Mark S. INCH, Secretary, Florida Department of Corrections, Appellee.

No. 1D18-2411

District Court of Appeal of Florida, First District.

June 4, 2019

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
[NOT FOR PUBLICATION–NOT TO BE CITED AS PRECEDENT]



# United States Court of Appeals

**For the First Circuit**

No. 99-2072 UNITED STATES, Appellee,
v. JULIO QUINONES-MELENDEZ, Defendant, Appellant.
APPEAL FROM THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF PUERTO RICO
[Hon. Salvador E. Casellas, U.S. District Judge ] Before Torruella, Chief Judge , Boudin and Lipez, Circuit Judges .
Norberto Colon on brief for appellant. Gui llermo Gil , United States Attorney, Jorge E. VegaPacheco , Assistant United States Attorney, and Nelson PerezSosa , Assistant United States Attorney, on brief for appellee.

July 13, 2000Per Curiam . After a thorough review of the record

and of the parties’ submissions, we affirm.

Because appellant Julio Quiñones Meléndez (“Quiñones”) did not object below to the sentencing court’s findings regarding drug quantity or his role in the offense, those arguments are forfeited. See United States v. Bayes , 210 F.3d 64, 67 (1 st Cir. 2000); Fed. R. Crim. P. 52(b). Even if they had not been forfeited, they are without merit. Quiñones admitted under oathat the Rule 11 hearing that he was guilty of the charge of conspiring to possess more than five kilograms of cocaine, so we see no clear error in the court’s decision to credit those sworn admissions. See United States v. Marrero-Rivera , 124 F.3d 342, 354 (1 st Cir. 1997). As for his role in the offense, this court would onlyreview for clear error, and we see none. See United States v. Ortiz-Santiago , 211 F.3d 146, 148-49 (1 st Cir. 20 00). Quiñones agreed that the adjustment for a “minor” role under U.S.S.G. § 3B1.2(b) should apply; and because the government agreed to understate the quantity of drugs for which Quiñones was to be held responsible, the sentencing court was entitled to deny him a more generous role in the offense adjustment. Id. at 149.-3- Quiñones also complains that he has not been assigned to serve his sentence in a rehabilitation camp, despite the recommendation of the sentencing court. But the authorityto assign prisoners to particular facilities lies solely with the Bureau of Prisons. See 18 U.S.C. § 3621.

Affirmed. 1 st Cir. Loc. R. 27(c).
J. P., a juvenile, Appellant, v. The STATE of Florida, Appellee.

No. 3D18-1530

District Court of Appeal of Florida, Third District.

Opinion filed May 29, 2019

Carlos J. Martinez, Public Defender, and Natasha Baker-Bradley, Assistant Public Defender, for appellant.

Ashley Moody, Attorney General, and Christina L. Dominguez, Assistant Attorney General, for appellee.

Before LOGUE, LINDSEY, and HENDON, JJ.

PER CURIAM.

Affirmed.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED BALANCE SHEET AT JUNE 30, 1997 AND THE CONDENSED
CONSOLIDATED STATEMENT OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 1997
AS INCLUDED IN THE FORM 10Q FOR THE QUARTERLY PERIOD ENDED JUNE 30, 1997 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                           1,980
<SECURITIES>                                         0
<RECEIVABLES>                                   63,016
<ALLOWANCES>                                         0
<INVENTORY>                                     51,421
<CURRENT-ASSETS>                               122,772
<PP&E>                                          12,846
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 241,012
<CURRENT-LIABILITIES>                           98,043
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                     31,600
<COMMON>                                           496
<OTHER-SE>                                      98,286
<TOTAL-LIABILITY-AND-EQUITY>                   241,012
<SALES>                                         57,592
<TOTAL-REVENUES>                                57,828
<CGS>                                           38,722
<TOTAL-COSTS>                                   38,722
<OTHER-EXPENSES>                                13,720
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,147
<INCOME-PRETAX>                                  4,239
<INCOME-TAX>                                     1,623
<INCOME-CONTINUING>                              2,349
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,349
<EPS-PRIMARY>                                      .11
<EPS-DILUTED>                                      .11
        

</TABLE>
IN THE

TENTH COURT OF APPEALS

No. 10-15-00003-CV

CITY OF MCGREGOR,

Appellant

v.

LAURA GARRETT, INDIVIDUALLY, 

AS REPRESENTATIVE OF THE ESTATE 

OF XX, DECEASED, HER MINOR SON, &

AS A WRONGFUL DEATH BENEFICIARY; 

AND RICKY THOMAS, AS REPRESENTATIVE

OF THE ESTATE OF XX, DECEASED, HIS MINOR

SON, & AS A WRONGFUL DEATH BENEFICIARY,

Appellees

From the 170th District Court

McLennan County, Texas

Trial Court No. 2014-1793-4

MEMORANDUM OPINION

Appellees have filed an “Unopposed Motion to Dismiss Appeal Without 

Deciding the Merits of the Appeal.” The motion states that the parties have settled the 

dispute underlying this appeal and requests that we dismiss the appeal without 
City of McGregor v. Garrett Page 2

deciding the merits and remand the case to the trial court for entry of judgment in 

accordance with the parties’ agreement.

The motion is granted. Accordingly, we set aside the trial court’s judgment

without regard to the merits, dismiss this appeal, and remand the case to the trial court 

for rendition of judgment in accordance with the parties’ agreement. See TEX. R. APP. P. 

42.1(a)(2)(B). 

REX D. DAVIS

Justice

Before Chief Justice Gray,

Justice Davis, and 

Justice Scoggins

Dismissed and remanded

Opinion delivered and filed March 26, 2015

[CV06]
{ U.S. FOOD & DRUG ,/-"",,, Ii 

\:I- ADMINISTRATION 

Food and Drug Administration Advisory Committee Member 

Acknowledgment of Financial Interests 

Name of Advisory Committee Member: Jeffrey M. Feldman, M.D., M.S.E. 

Committee: Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices Advisory 

Committee 

Meeting Date: February 2, 2024 

I acknowledge that contingent upon public disclosure of the following financial interest(s) related to the 

agenda items: The committee will discuss ongoing concerns that pulse oximeters may be less accurate in 

individuals with darker skin pigmentation. The committee will also discuss an approach to improve the 

quality of premarket studies and associated methods used to evaluate the performance of pulse oximeters 

submitted for premarket review, taking into consideration a patient’s skin pigmentation, and patientreported race and ethnicity, I may be considered for participation in the advisory committee meeting 

described above. 

Type of Interest Nature Magnitude 

I. Personal/Immediate Family 

Stock/investment Financial interest in a 

health sciences sector fund 

Value is between $75,000 -

$125,000 

II. Other Imputed Interests 

Employer’s Grant Federal Grant Amount awarded between 

$250,000 – $600,000 

annually 

I hereby request that FDA make this information publicly available on my behalf if the agency grants a waiver 

allowing me to participate in the meeting described above. I understand that without public disclosure of these 

interests, I will not participate in the advisory committee meeting described above. 

_______/S/__________________ _January 2, 2024________ 

Signature Date 

U.S. Food & Drug Administration 

10903 New Hampshire Avenue 

Silver Spring, MD 20993 

w ww.fda.gov
[Federal Register Volume 60, Number 86 (Thursday, May 4, 1995)]
[Notices]
[Page 22054]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-10998]



-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE
Department of the Navy


Board of Advisors to the President, Naval War College, Meeting

    Pursuant to the provisions of the Federal Advisory Committee Act (5 
U.S.C. app.), notice is given that the Board of Advisors to the 
President, Naval War College, will meet on May 31, and June 1, 1995, in 
Room 210, Conolly Hall, Naval War College, 686 Cushing Road, Newport, 
Rhode Island. The meeting will commence at 8:30 a.m. on May 31, and 
terminate at approximatetly 12:00 p.m. on June 1, 1995.
    The purpose of the meeting is to elicit the advice of the Board on 
educational, doctrinal, and research policies and programs. The agenda 
will consist of presentations and discussions on the curriculum, 
programs and plans of the College, and is open to the public.
    For further information contact: Mrs. Mary E. Estabrooks, Assistant 
to the Dean of Academics, Naval War College, 686 Cushing Road, Newport, 
RI 02841-1207. Telephone number (401) 841-3589.

    Dated: April 24, 1995.
L.R. McNees,
LCDR, JAGC, USN, Federal Register Liaison Officer.
[FR Doc. 95-10998 Filed 5-3-95; 8:45 am]
BILLING CODE 3810-FF-F
Andrew John KALINOWSKI, Appellant, v. STATE of Florida, Appellee.

Case No. 2D18-4838

District Court of Appeal of Florida, Second District.

Opinion filed July 3, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.